AbCellera Named to 2016 Life Science Emerging Rockets List of High Growth Companies

March 02, 2016

AbCellera identified with top technology companies in BC

Vancouver, Canada (March 2, 2016) - Authored by technology consulting firm Rocket Builders for 14 consecutive years, the list identifies tech companies in British Columbia (BC) that are “best positioned to capitalize on technology trends that will lead them to faster growth than their peers”.

“We believe next-generation antibody therapies have the potential to significantly impact the future of medicine and human health,” says Dr. Carl Hansen, President and CEO of AbCellera. “We’ve had a number of innovative partnerships with global pharma and biotech organizations in recent months and are excited to be recognized among BC’s high growth companies.”

The 2016 Life Science Emerging Rockets list includes nine other technology companies in BC, and can be viewed at

About AbCellera Biologics Inc.  AbCellera is a privately held biotechnology company that provides enabling technologies for the discovery and development of monoclonal antibody (mAb) therapies directly from natural immune cells.

AbCellera’s lead technology is a proprietary single cell antibody discovery platform that provides pharma and biotech partners with the ability to rapidly identify mAb therapeutic candidates from the natural immune repertoires of any species, including humans. 

Contact  Kevin Heyries  Telephone: 604.827.4151  Email:

About Ready to Rocket  Ready to Rocket is a unique business recognition list that profiles technology companies with the greatest potential for growth. Each year, based on analysis of trends, Rocket Builders identifies the top private companies that are best positioned to capitalize on these trends to achieve growth. This selection methodology has been an accurate predictor of investment and business success with past "Ready to Rocket" companies. 

Trademark Notice  “Ready to Rocket” is a trademark of Rocket Builders, a respected management consulting firm servicing the technology industry.